Doctors told Jamie Mains there was no medication for meth addiction. Six months later, she discovered something that worked better than any pill. A clinic would pay her to stay clean.

“For me, money was a good enough reason to try,” Mains said.

The concept of paying meth users to quit sounds absurd to many people. Critics call it bribery. Others question using tax dollars to reward people for behaviour most consider basic decency. But research tells a different story.

Why Money Works When Medicine Fails

Unlike opioid addiction, which responds to replacement medications like methadone, meth addiction has no pharmaceutical solution. The drug floods the brain with dopamine levels that reach 1,000 times normal baseline – far beyond what any medication can safely counteract.

Dr. Kristen Silvia explains it to patients this way: on an ordinary day, dopamine levels might hit 50. The best meal or best day of your life might push levels to 100. Crack cocaine can spike levels to 300. But meth sends dopamine soaring to 1,000 and keeps it there for hours.

No medication can compete with that chemical tsunami. So clinics are trying something radically different.

How Paying Meth Users to Quit Actually Works

The approach, called contingency management, operates on simple psychology. Patients visit clinics twice weekly for urine tests. Clean results earn immediate rewards – store vouchers, debit card cash, or small prizes.

The amounts start modest. Mains earned $10 for her first negative test, then $12.50 for the second. Rewards increase with sustained abstinence, typically reaching cumulative values near $600 over three to six months.

The immediacy matters. Unlike distant goals or vague promises, patients receive tangible rewards within minutes of testing clean. These small victories trigger dopamine releases that help rewire addiction patterns.

The Evidence Behind the Controversy

Research consistently shows contingency management produces better outcomes than counseling or cognitive behavioural therapy for stimulant addiction. Follow-up studies indicate about half of patients remain drug-free a year after completing programmes.

The approach isn’t new – it’s existed for decades. But most clinics avoided it because of the uncomfortable transaction involved. Paying meth users to quit feels wrong to many healthcare providers trained to view addiction through moral rather than medical frameworks.

Dr. Sally Satel, medical director at a methadone clinic in Washington, acknowledges the discomfort. “Most people recoil at paying people to do the right thing,” she said. “But we’ve got plenty of data that shows this works. So I think we just have to bite the utilitarian bullet.”

Real Results from Real People

Mains’s story illustrates how effective the approach can be. Desperate to see her grandson, she entered a pilot programme at Spurwink clinic in Portland, Maine, in early 2024.

She moved into a shelter to endure withdrawal. Her first clean test earned encouraging smiles from clinic staff and $10 on a debit card. She used the money to buy overdue Christmas gifts for her grandson.

“I could not remember when exhilaration had sprung from pride and joy, rather than from drugs,” she recalled.

With each negative test, rewards increased and her life improved. She moved to sober housing, started volunteering, began attending church three times weekly. The programme helped her address childhood trauma that drugs had masked – binge drinking at age 9, trying heroin at 12.

Rapid Expansion Despite Controversy

The Department of Veterans Affairs pioneered contingency management, treating over 8,000 veterans since 2011. During the pandemic, as meth-related deaths climbed, the Biden administration cautiously expanded federal support.

Now programmes are spreading rapidly. Treatment experts estimate over 600 sites operate nationwide, including 109 in California. San Francisco launched “Cash Not Drugs” in January. Pennsylvania’s Allegheny County rewards patients up to $1,000 annually.

Private employers are authorising insurance coverage. New apps allow rural patients to access programmes through telehealth. Some programmes experiment with different reward structures to optimise individual responses.

Paying Meth Users to Quit Faces Political Headwinds

The approach’s future remains uncertain under the Trump administration. Many believe Robert F. Kennedy Jr., the health secretary nominee, would oppose financial rewards-based strategies. Kennedy overcame heroin addiction through 12-step programmes and has praised approaches that threaten jail for treatment refusal.

The Department of Health and Human Services declined to comment on potential policy decisions, stating only that it “must return to common-sense public health approaches focused on prevention, treatment, and long-term recovery.”

Critics worry that paying meth users to quit resembles welfare benefits and creates dependency on rewards rather than genuine recovery. Some patients do game the system, substituting clean urine samples or trading rewards for drugs.

Technology Closes Loopholes

Programmes are adapting to prevent abuse. Tech companies can block debit card purchases for gambling, tobacco, alcohol, or firearms. Some sites switched to mouth swabs that therapists can observe directly.

Apps like DynamiCare require patients to record themselves taking saliva tests on phone cameras. Staff review recordings before releasing rewards through the app.

Legal concerns persist. Most programmes cap awards at $599 to avoid federal tax reporting requirements for earnings over $600. Allegheny County’s lawyers argue their $1,000 incentive qualifies for tax exclusions for low-income individuals.

The Funding Challenge

Medicaid traditionally didn’t cover contingency management. In 2021, federal authorities allowed states to apply for pilot programmes – an arduous process. Only California, Montana, Washington, and a handful of others have gained approval.

As meth use grew and contingency management’s success became evident, 40 states lobbied for increased federal support. In January, the Biden administration raised cumulative award caps from $75 to $750 per patient, provided rewards come as gift cards or services, not cash.

Uncertain about policy continuity, public health officials seek grants from opioid litigation settlement funds. Michigan, Rhode Island, Vermont, Virginia, and Arizona’s Maricopa County have started programmes with settlement money.

Beyond the Money

Sixteen months after her first clean test, Mains remains sober. The initial financial incentives evolved into something deeper.

“I was getting paid not to use and that was nice and that was the beginning,” she said. “But now I feel like being sober is payment enough, not waking up sick is payment enough, being trusted is payment enough.”

Paying meth users to quit challenges conventional thinking about addiction and recovery. It treats addiction as a medical condition requiring practical interventions rather than moral failing requiring punishment.

The approach works precisely because it acknowledges human nature rather than fighting it. Small, immediate rewards help rebuild the neurochemical pathways that addiction destroys.

For people like Mains, facing a drug that has no medical antidote, money provided the bridge between active addiction and sustainable recovery. Whether society will embrace this pragmatic solution remains to be seen.

Source: The New York Times